Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DEVICE REVIEW SHIELDING FROM S 830 IMPLEMENTATION BURDENS TO BE FOCUS OF INDUSTRY REPS AT MEETING WITH AGENCY; FDA COMMISSIONER WATCH FOCUSES ON HENNEY

This article was originally published in The Gray Sheet

Executive Summary

Ensuring that implementation of the FDA reform bill signed into law Nov. 21 does not slow down premarket device reviews will be one of the priorities underscored by industry participants at a Nov. 24 implementation task force meeting with Center for Devices and Radiological Health staffers, industry reps say.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009139

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel